Serum midkine levels are increased in patients with various types of carcinomas - Wikidata - awgldk - TriplyDB

Serum midkine levels are increased in patients with various types of carcinomas

Serum midkine levels are increased in patients with various types of carcinomas

http://www.wikidata.org/entity/Q24649020

about

Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas Involvement of midkine in neuroblastoma tumourigenesis Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types Inhibition of the growth factor MDK/midkine by a novel small molecule compound to treat non-small cell lung cancer Construction of a fusion protein expression vector MK-EGFP and its subcellular localization in different carcinoma cell lines.Expression of midkine and its clinical significance in esophageal squamous cell carcinoma.Diagnostic accuracy of ELISA for detecting serum Midkine in cancer patients.Midkine inhibitors: application of a simple assay procedure to screening of inhibitory compounds The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer.Role of the endothelium in inflammatory bowel diseases.Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1 New molecular mediators in tumor angiogenesis.Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).The cytokine midkine and its receptor RPTPζ regulate B cell survival in a pathway induced by CD74.Midkine: a promising molecule for drug development to treat diseases of the central nervous system Role of midkine-progranulin interaction during angiogenesis of hepatocellular carcinoma Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray.Rationale for clinical trials of coagulation: reactive drugs in hepatocellular carcinoma.Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids.Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium Midkine, a heparin-binding cytokine with multiple roles in development, repair and diseases.The advances of Midkine with peripheral invasion in pancreatic cancer.The growth factor Midkine antagonizes VEGF signaling in vitro and in vivo Clinical significance of midkine expression in pancreatic head carcinoma.Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patients.Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma.Midkine as a prognostic biomarker in oral squamous cell carcinoma.Midkine: A Novel Biomarker to Predict Malignancy in Patients with Nodular Thyroid Disease.The growth factor midkine regulates the renin-angiotensin system in mice A list of candidate cancer biomarkers for targeted proteomics.Midkine: a novel prognostic biomarker for cancer.Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer.Midkine in the pathology of cancer, neural disease, and inflammation.The heparin-binding growth factor midkine: the biological activities and candidate receptors.Midkine as a regulator of B cell survival in health and disease.Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.Efficacy of urinary midkine as a biomarker in patients with acute kidney injury.

P2860

Q24656678-91366156-5A4F-400D-850D-E6316A418DD4 Q27026748-8C259FCD-C7C4-47F6-BBF7-BED304CAC4B3 Q28214927-6D0013F7-EAE0-498B-8B52-45C708B67377 Q28535406-9D8503FC-A43E-434A-AD94-5DF23D424C09 Q33266700-22ACCB63-2048-474A-A863-3047F40AE796 Q33867253-A4E2A4F6-512B-4483-8B7B-EABAC24F6069 Q33884098-040F96A1-8442-45B4-B12A-06192CC5F9B1 Q33968267-3980AAC8-A858-4301-A112-5552217CF84B Q34198587-0007913B-CC16-41E3-96E5-000BFAB39DF6 Q34579746-D35D3542-DEE6-4342-A733-88F53860936C Q34624412-61DBB906-11D5-4522-BC41-A708F43C1790 Q34687698-7872D8DC-7AF0-4E1E-AD74-2E39B1B8CDCB Q35027553-1C35C94E-0B65-45D1-A541-AABC9EE7FA4C Q35629314-6AD839A4-9ABA-4494-80AE-F06ED916A79D Q35701268-D108A508-1588-469A-8DF5-F8CA591278C2 Q35805773-34C2A051-3B0F-4175-AE38-FFAEA38AF9FC Q35842022-E5FA3C1D-38D3-442D-BD03-30D7665EC2C7 Q35879110-5094281D-A81C-4995-947D-82A1A3ADF5A4 Q35903066-46BD6981-F237-4F64-ADFC-063D9A14E9AE Q35957217-A3BE5993-616C-4FD9-AF91-5341C1FC3885 Q36160231-CB68654D-BB18-4DDE-8547-9126750D2941 Q36250696-E2ED6E7E-6394-458D-A6FF-A021C90051D4 Q36528210-12804DBD-2595-49A5-A9AE-8C849C8FF599 Q36610901-C8D5A8C4-3D47-4E76-BF08-41E0E9D5DC4D Q36623775-248617E8-6FC3-413F-A46B-026EFF8D2534 Q36706828-FB3B8AAC-375C-4FE4-9C0E-F1ABAE6A8FA4 Q36858230-90A9DFE6-6C90-4EA0-81F3-F54BB5F22CA1 Q37092811-A1EDC630-3BF6-414F-8B73-A6E94B3C203F Q37209205-AF78846D-8E59-42BE-BF14-B5D30851F6B5 Q37277962-34DDDBA8-8003-4540-8289-3CF66E162CF7 Q37328317-5DB2F14F-B1C3-47BE-A73A-3AEC80CF1927 Q37699449-F190FB35-76EA-4245-A87C-7AFF378DC688 Q38020971-9B6ABC72-DE51-40E6-8893-518EB2BFF0FE Q38102670-E7B623EA-9BE6-47DF-8557-301355B912B2 Q38151163-C8790E76-4DB2-49C5-9A0F-BC22DFAF525F Q38181600-04B2E66F-732B-4BE9-841D-5F44FA61A046 Q39171951-4E736FED-1034-4953-960C-A1935C2AE120 Q39937384-79260DFE-FCA6-493F-BA96-5D874AC038B7 Q40056869-633B8834-2F61-4CAE-9E72-B3822D9A5398 Q40619565-1338666A-CCD3-49F7-9345-2D76B134A654

P2860

Serum midkine levels are increased in patients with various types of carcinomas

http://www.wikidata.org/entity/Q24649020

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Serum midkine levels are increased in patients with various types of carcinomas

@ast

Serum midkine levels are increased in patients with various types of carcinomas

@en

Serum midkine levels are increased in patients with various types of carcinomas

@nl

type

label

Serum midkine levels are increased in patients with various types of carcinomas

@ast

Serum midkine levels are increased in patients with various types of carcinomas

@en

Serum midkine levels are increased in patients with various types of carcinomas

@nl

prefLabel

Serum midkine levels are increased in patients with various types of carcinomas

@ast

Serum midkine levels are increased in patients with various types of carcinomas

@en

Serum midkine levels are increased in patients with various types of carcinomas

@nl

P1433

Q24649020-091FAC7B-8244-4AE7-A845-7CD5CD2E3127

P1476

Q24649020-441D67AB-DEE1-4822-88F7-64B792D5A81C

P2093

Q24649020-0F702797-F95D-4FF1-8191-6AAF07D33710

Q24649020-43FD56E5-E352-47C8-8F1B-AE15F84D3E29

Q24649020-731CA1A4-9B51-4686-A983-84EA8B1F2B81

Q24649020-9AC769CF-D0E3-4C48-B8F1-988D187763D3

Q24649020-B689E01E-79E1-4576-ACC4-8E63E0073762

Q24649020-C5506CB9-E5BF-4BAD-95FF-0B6DED09165D

Q24649020-C5A64D9A-D0E4-42B3-8599-D5198983FEC9

Q24649020-CCED2049-E406-437D-9845-1ED89BA85239

Q24649020-CE683470-736A-40F6-AB76-9EC56AAE437B

Q24649020-D3EFA343-B2D2-45DC-A94F-110462EED904

P2860

Q24649020-06F5A7A5-1A24-4402-9C81-4C603852AC6A

Q24649020-07477742-DE9A-48D7-BCBD-F67322508ED3

Q24649020-243FBE3B-22BE-4028-B8EF-5DE8391BA858

Q24649020-4017338D-DA67-43B5-8EC4-FE9646C3B36E

Q24649020-49402162-71BE-403B-9368-ADBDE7C7D5DD

Q24649020-4AF73AF3-B400-4DAC-8E34-97F8C2F599B9

Q24649020-755B7713-D79E-46B4-9BA9-575BE52B8417

Q24649020-876A1193-7450-49DE-A520-BF286AFB70CE

Q24649020-89905D1C-57B8-484B-AF08-72AFCDF8EBF2

Q24649020-8C6CFF99-BB26-48EB-A61A-8B7BE6473EF6

P2888

Q24649020-C3F367CD-ECA1-4066-B7E8-21A9F8E0B668

P304

Q24649020-964B12AA-A8FD-4B93-80DD-DD6617D1947E

P31

Q24649020-917C64E5-7439-4DF2-996C-3F80B0653386

P3181

Q24649020-AAD639BA-1745-4966-ACD0-9122752347B2

P356

Q24649020-ED0A80D9-89DE-49A5-AE40-597CE64D7B16

P407

Q24649020-FB1A197E-DF00-49CF-8F7B-8BA5DD063C2E

P433

Q24649020-6695A83E-58C5-4393-874F-397DC3EAD26B

P478

Q24649020-02C474D7-9EF4-4F75-9676-2DA00C401793

P577

Q24649020-4E33CC54-5F07-4A20-AC26-3AC5EC453760

P5875

Q24649020-BE146EC7-41D6-49B8-AC37-B309809B4B4F

P6179

Q24649020-42429387-C598-4A97-8A42-B7BB3FC5048F

P698

Q24649020-715BA8B2-471F-49B5-A786-FE9444057EFB

P932

Q24649020-F0A47C60-0A9B-4C35-8831-FE447546E3A2

P3181

P356

P1433

British Journal of Cancer

P1476

Serum midkine levels are increased in patients with various types of carcinomas

@en

P2093

A Yano

http://www.w3.org/2001/XMLSchema#string

H Kumai

http://www.w3.org/2001/XMLSchema#string

H Muramatsu

http://www.w3.org/2001/XMLSchema#string

H Nagano

http://www.w3.org/2001/XMLSchema#string

K Aridome

http://www.w3.org/2001/XMLSchema#string

K Kadomatsu

http://www.w3.org/2001/XMLSchema#string

K Okamoto

http://www.w3.org/2001/XMLSchema#string

M Kikuchi

http://www.w3.org/2001/XMLSchema#string

M Oda

http://www.w3.org/2001/XMLSchema#string

S Ikematsu

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity

A receptor-like protein-tyrosine phosphatase PTPzeta/RPTPbeta binds a heparin-binding growth factor midkine. Involvement of arginine 78 of midkine in the high affinity binding to PTPzeta

Neointima formation in a restenosis model is suppressed in midkine-deficient mice

A Receptor-like Protein-tyrosine Phosphatase PTP /RPTP Binds a Heparin-binding Growth Factor Midkine: INVOLVEMENT OF ARGININE 78 OF MIDKINE IN THE HIGH AFFINITY BINDING TO PTP

A new heparin binding protein regulated by retinoic acid from chick embryo.

Molecular cloning of the 18-kDa growth-associated protein of developing brain.

Differential expression of pleiotrophin and midkine in advanced neuroblastomas.

Retinoic acid responsive gene product, midkine, has neurotrophic functions for mouse spinal cord and dorsal root ganglion neurons in culture.

A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.

Increased expression of midkine during the progression of human astrocytomas.

P2888

P304

701-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

378027

http://www.w3.org/2001/XMLSchema#string

P356

10.1054/BJOC.2000.1339

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12367752

http://www.w3.org/2001/XMLSchema#string

P6179

1022813702

http://www.w3.org/2001/XMLSchema#string

P698

10952771

http://www.w3.org/2001/XMLSchema#string

P932

2363529

http://www.w3.org/2001/XMLSchema#string